Matthias Rothermundt
Muenster, NW, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 24 publications
Mapping genomic loci implicates genes and synaptic biology in schizophrenia.
Journal: Nature
Published: August 12, 2020
Blood-based immune-endocrine biomarkers of treatment response in depression.
Journal: Journal of psychiatric research
Published: June 23, 2016
Molecular serum signature of treatment resistant depression.
Journal: Psychopharmacology
Published: December 23, 2015
Prenatal immune activation in mice blocks the effects of environmental enrichment on exploratory behavior and microglia density.
Journal: Progress in neuro-psychopharmacology & biological psychiatry
Published: November 09, 2015
Serum S100B Protein is Specifically Related to White Matter Changes in Schizophrenia.
Journal: Frontiers in cellular neuroscience
Published: November 01, 2015
Pretreatment levels of the fatty acid handling proteins H-FABP and CD36 predict response to olanzapine in recent-onset schizophrenia patients.
Journal: Brain, behavior, and immunity
Published: July 24, 2015
Proteolytic degradation of neuropeptide Y (NPY) from head to toe: Identification of novel NPY-cleaving peptidases and potential drug interactions in CNS and Periphery.
Journal: Journal of neurochemistry
Published: July 22, 2015
Towards a blood-based diagnostic panel for bipolar disorder.
Journal: Brain, behavior, and immunity
Published: May 26, 2015
S100B Serum Levels Predict Treatment Response in Patients with Melancholic Depression.
Journal: The international journal of neuropsychopharmacology
Published: May 19, 2015
Development of a blood-based molecular biomarker test for identification of schizophrenia before disease onset.
Journal: Translational psychiatry
Published: April 29, 2015
Normal cerebellar development in S100B-deficient mice.
Journal: Cerebellum (London, England)
Published: October 25, 2014
Last Updated: 09/26/2026